Scientech Research »

Intellia Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2024-03-31 $556k 20k 27.51

More positions owned by Scientech Research

Cadence Design Systems (CDNS)
Regeneron Pharmaceuticals (REGN)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)
Nikola Corp (NKLA)
Mastercard Incorporated Cl A (MA)
Monolithic Power Systems (MPWR)
Thermo Fisher Scientific (TMO)
Saia (SAIA)
Dover Corporation (DOV)
Icon SHS (ICLR)
Synopsys (SNPS)
Crowdstrike Hldgs Cl A (CRWD)
Meta Platforms Cl A (META)
Carlisle Companies (CSL)

View all positions for Scientech Research

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Wellington Management Company
FMR
Geode Capital Management
Federated Investors
Casdin Capital
Alliancebernstein
T. Rowe Price Associates
Rokos Capital Management
Contrarius Investment Management

View all funds holding Intellia Therapeutics